133 related articles for article (PubMed ID: 3602041)
1. Effect of phencyclidine and two monohydroxy metabolites on 3H QNB binding in vivo in rats.
Boggan WO; Stringer AJ; Faught K; Middaugh LD
Pharmacol Biochem Behav; 1987 Apr; 26(4):847-9. PubMed ID: 3602041
[TBL] [Abstract][Full Text] [Related]
2. Doubtful role for phencyclidine metabolites in PCP enhancement of QNB binding.
Boggan WO; Middaugh LD
Pharmacol Biochem Behav; 1987 Apr; 26(4):671-6. PubMed ID: 3602029
[TBL] [Abstract][Full Text] [Related]
3. Parametric studies on phencyclidine enhancement of 3H quinuclidinyl benzilate accumulation in vivo.
Boggan WO; Faught K; Boyd S; Middaugh LD
Pharmacol Biochem Behav; 1988 May; 30(1):31-5. PubMed ID: 3174753
[TBL] [Abstract][Full Text] [Related]
4. Effect of phencyclidine on [3H]QNB binding.
Boggan WO; Evans MG; Wallis CJ
Life Sci; 1982 Apr; 30(14):1193-1200. PubMed ID: 7087659
[TBL] [Abstract][Full Text] [Related]
5. Effect of central injection of phencyclidine on QNB accumulation and motor activity.
Boggan W; Middaugh L
Eur J Pharmacol; 1989 Jul; 166(2):123-9. PubMed ID: 2792187
[TBL] [Abstract][Full Text] [Related]
6. Effect of dopaminergic drugs on enhancement of the binding of quinuclidinyl benzilate by phencyclidine in vivo.
Boggan WO; Middaugh LD; Faught K
Neuropharmacology; 1989 Jun; 28(6):617-24. PubMed ID: 2569176
[TBL] [Abstract][Full Text] [Related]
7. Some factors affecting phencyclidine biotransformation by human liver and placenta.
Pohorecki R; Rayburn W; Coon WW; Domino EF
Drug Metab Dispos; 1989; 17(3):271-4. PubMed ID: 2568907
[TBL] [Abstract][Full Text] [Related]
8. Chemical synthesis and molecular pharmacology of hydroxylated 1-(1-phenylcyclohexyl-piperidine derivatives.
Kamenka JM; Chiche B; Goudal R; Geneste P; Vignon J; Vincent JP; Lazdunski M
J Med Chem; 1982 Apr; 25(4):431-5. PubMed ID: 6279847
[TBL] [Abstract][Full Text] [Related]
9. Effects of kamikihito, a traditional Chinese medicine, on neurotransmitter receptor binding in the aged rat brain determined by in vitro autoradiography (1): Changes in the [3H]QNB binding.
Hayashi T; Yamada K; Hasegawa T; Ishihara S; Kameyama T; Morimasa T; Kaneyuki T; Shohmori T; Nabeshima T
Jpn J Pharmacol; 1994 Apr; 64(4):303-6. PubMed ID: 8057532
[TBL] [Abstract][Full Text] [Related]
10. Binding of [3H]quinuclidinyl benzilate to regions of rat pituitary and hypothalamus.
Hoover DB; Hancock JC; Talley NS
Brain Res Bull; 1981 Mar; 6(3):209-11. PubMed ID: 7225899
[TBL] [Abstract][Full Text] [Related]
11. Effects of acetylethylcholine mustard on [3H]quinuclidinyl benzilate binding and acetylcholine release in rat brain synaptosomes.
Meyer EM; Otero DH; Morgan E; Marchand S; Baker SP
J Neurochem; 1987 Feb; 48(2):477-82. PubMed ID: 3794717
[TBL] [Abstract][Full Text] [Related]
12. Discriminative properties of phencyclidine in mice: generalization to ketamine and monohydroxy metabolites.
Middaugh LD; Favara JP; Boggan WO; Stringer AJ
Psychopharmacology (Berl); 1988; 96(3):381-4. PubMed ID: 3146772
[TBL] [Abstract][Full Text] [Related]
13. Binding of [3H]quinuclidinyl benzilate to intestinal mucus. An artifact in identification of epithelial cell muscarinic receptors.
Rimele TJ; Gaginella TS
Biochem Pharmacol; 1982 Feb; 31(4):515-20. PubMed ID: 7066020
[TBL] [Abstract][Full Text] [Related]
14. Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain.
Luthin GR; Wolfe BB
J Pharmacol Exp Ther; 1984 Mar; 228(3):648-55. PubMed ID: 6546770
[TBL] [Abstract][Full Text] [Related]
15. Differential interactions of muscarinic drugs with binding sites of [3H]pirenzepine and [3H]quinuclidinyl benzilate in rat brain tissue.
Tonnaer JA; van Vugt MA; de Boer T; de Graaf JS
Life Sci; 1987 May; 40(20):1981-7. PubMed ID: 3573989
[TBL] [Abstract][Full Text] [Related]
16. Cholinergic muscarinic receptors in rat myocardium: properties of [3H]quinuclidinyl benzilate [QNB] binding sites.
Mittal CK
Indian J Exp Biol; 1985 Jun; 23(6):300-5. PubMed ID: 4077129
[No Abstract] [Full Text] [Related]
17. Phenylclindine-induced alteration in rat muscarinic cholinergic receptor regulation.
Ward D; Trevor A
Eur J Pharmacol; 1981 Sep; 74(2-3):189-93. PubMed ID: 7327201
[TBL] [Abstract][Full Text] [Related]
18. Effects of lithium on [3H](-)quinuclidinyl benzilate [( 3H](-)QNB) binding to rat brain muscarinic cholinergic receptors.
Hruska RE; Ludmer LM; Pert A; Bunney WE
J Neurosci Res; 1984; 11(2):171-7. PubMed ID: 6423831
[TBL] [Abstract][Full Text] [Related]
19. Potency ratio for the inhibition of 3H-QNB and 3H-cis-methyldioxolane binding predicts agonist or antagonist activity on muscarinic receptors.
Moret C; Pastrie I; Briley M
Methods Find Exp Clin Pharmacol; 1988 Oct; 10(10):619-21. PubMed ID: 3236936
[TBL] [Abstract][Full Text] [Related]
20. Phencyclidine: behavioral and biochemical evidence against the anticholinergic hypothesis.
Johnson KM
Pharmacol Biochem Behav; 1982 Jul; 17(1):53-7. PubMed ID: 7122667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
